XML 31 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
Events Associated with the Amalgamation of Global Crossing (Details) (USD $)
1 Months Ended 3 Months Ended 6 Months Ended 1 Months Ended 12 Months Ended 0 Months Ended 1 Months Ended 0 Months Ended
Oct. 19, 2011
Mar. 31, 2011
Mar. 31, 2012
Oct. 04, 2011
Oct. 03, 2011
Oct. 31, 2011
Senior Secured Term Loan
Tranche B II Term Loan
Dec. 31, 2011
Senior Notes due 2019 (8.125%)
Mar. 31, 2012
Senior Notes due 2019 (8.125%)
Oct. 04, 2011
Common stock
Oct. 31, 2011
Common stock
Nov. 30, 2011
Global Crossing
Oct. 04, 2011
Global Crossing
Oct. 04, 2011
Global Crossing
2% Cumulative convertible preferred stock
Acquisition                          
Amalgamation stock exchange ratio (in shares)                 16        
Preferred stock dividend rate (as a percent)                         2.00%
Additional principal amount of debt issued           $ 650,000,000              
Proceeds from issuance of 8.125% Senior Notes due 2019 in June and July 2011             1,200,000,000            
Debt instrument, stated interest rate (as a percent)               8.125%          
Shares issued in Amalgamation transaction (in shares)                   88,530,000      
Reverse stock split ratio (in shares) 15                        
Amount of outstanding debt redeemed and refinanced                     1,360,000,000    
Closing stock price         $ 21.15                
Estimated total Amalgamation transaction consideration     3,400,000,000                    
Cash Paid for Employee Income and Payroll Tax Witholdings 81,000,000                        
Initial Purchase Price Allocation [Abstract]                          
Cash, Cash Equivalents, and Restricted Cash       226,000,000                  
Property, Plant, and Equipment       3,098,000,000                  
Goodwill       1,069,000,000                  
Identifiable Intangibles       106,000,000                  
Other Assets       680,000,000                  
Total Assets       5,179,000,000                  
Long-term Debt       (1,554,000,000)                  
Other Liabilities       (1,663,000,000)                  
Total Liabilities       (3,217,000,000)                  
Total Estimated Consideration       1,962,000,000                  
Business Acquisition, Purchase Price Allocation, Reduction Due to Un Amortizable Deferred Revenue                       77,000,000  
Pro Forma Financial Information [Abstract]                          
Total Revenue   1,548,000,000                      
Net Loss   (232,000,000)                      
Net Loss per share (in dollars per share)   $ (1.16)                      
Acquisition related costs incurred     49,000,000                    
Acquisition related integration costs     $ 47,000,000